Fintel reports that on November 19, 2024, Evercore ISI Group upgraded their outlook for BioNTech SE - Depositary Receipt () ...

Echoing this, BioNTech stock's Schaeffer's put/call open interest ratio (SOIR) of 1.14 sits higher than 98% of annual ...

In a report released today, Harry Gillis from Berenberg Bank upgraded BioNTech SE (BNTX – Research Report) to a Buy, with a price target of $130.00. The company’s shares closed yesterday at $101.87.

BioNTech SE BNTX announced that it has entered into a definitive agreement to acquire China-based biotech, Biotheus, to ...

Berenberg initiated coverage of BioNTech (BNTX) with a Buy rating and $130 price target The firm says mRNA will revolutionize the treatment of ...

The S&P 500 Index Tuesday closed up +0.40%, the Dow Jones Industrials Index closed down -0.28%, and the Nasdaq 100 Index closed up +0.71%. Stocks on Tuesday recovered from early l ...

BioNTech SE BNTX announced that it has entered into a definitive agreement to acquire China-based biotech, Biotheus, to strengthen its oncology pipeline. With the acquisition, BNTX will gain full ...

BioNTech (BNTX) is up more than +2% after Berenberg initiated coverage on the stock with a buy recommendation and a price target of $130. Amer Sports Inc (AS), AZEK Co Inc/The (AZEK), Dolby ...

Shares of BioNTech stock opened at $99.72 on Thursday. BioNTech has a fifty-two week low of $76.53 and a fifty-two week high of $131.49. The company has a debt-to-equity ratio of 0.01, a quick ...